Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Authors
Keywords
-
Journal
LANCET
Volume 397, Issue 10281, Pages 1276-1292
Publisher
Elsevier BV
Online
2021-04-02
DOI
10.1016/s0140-6736(21)00314-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
- (2020) Esaú C João et al. Lancet HIV
- Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial
- (2020) Kenneth Kintu et al. Lancet HIV
- Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy
- (2020) Gerhard Theron et al. CLINICAL INFECTIOUS DISEASES
- Renal safety of tenofovir alafenamide vs tenofovir disoproxil fumarate
- (2019) Samir K. Gupta et al. AIDS
- Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes
- (2019) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
- (2019) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
- (2019) Willem D.F. Venter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
- (2018) Rebecca Zash et al. Lancet Global Health
- Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception
- (2018) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Committee Opinion No 700
- (2017) OBSTETRICS AND GYNECOLOGY
- A cost-savings analysis of a candidate universal antiretroviral regimen
- (2017) David Ripin et al. Current Opinion in HIV and AIDS
- Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy
- (2017) Rebecca Zash et al. JAMA Pediatrics
- Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana
- (2016) Rebecca Zash et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- INTERGROWTH-21st very preterm size at birth reference charts
- (2016) José Villar et al. LANCET
- Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
- (2016) Li Liu et al. LANCET
- Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
- (2016) Mary G. Fowler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global burden of prematurity
- (2016) Margo S. Harrison et al. Seminars in Fetal & Neonatal Medicine
- Ultrasound-based gestational-age estimation in late pregnancy
- (2016) A. T. Papageorghiou et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- Pregnancy dating by fetal crown-rump length: a systematic review of charts
- (2014) R Napolitano et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project
- (2014) José Villar et al. LANCET
- Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
- (2013) Peter J. Ruane et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclusion and exclusion criteria for malformations in newborn infants exposed to potential teratogens
- (2011) Lewis B. Holmes et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
- (2011) Jan van Lunzen et al. LANCET INFECTIOUS DISEASES
- Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana
- (2010) R.L. Shapiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recommendations for Weight Gain During Pregnancy in the Context of the Obesity Epidemic
- (2010) Kathleen M. Rasmussen et al. OBSTETRICS AND GYNECOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now